BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2859620)

  • 1. The anxiolytic activity of beta-carboline derivatives in mice, and its separation from ataxic properties.
    Stephens DN; Kehr W; Wachtel H; Schmiechen R
    Pharmacopsychiatry; 1985 Jan; 18(1):167-70. PubMed ID: 2859620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anxiolytic action of beta-carbolines in rats].
    Burov IuV; Orekhov SN; Vedernikova NN
    Biull Eksp Biol Med; 1985 Apr; 99(4):453-5. PubMed ID: 2859060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of beta-carboline derivatives on the evoked activity of hippocampal neurons].
    Glushankov PG; Pliashkevich IuG; Skrebitskiĭ VG; Demushkin VP
    Biull Eksp Biol Med; 1984 Aug; 98(8):211-3. PubMed ID: 6147169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction].
    Talalaenko AN
    Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
    Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
    J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxioselective anxiolytics: can less be more?
    Basile AS; Lippa AS; Skolnick P
    Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethological pharmacology of anxiogenic and anxiolytic drugs.
    Poshivalov VP; Suchotina IA; Verbitzkaya EV
    Ann Ist Super Sanita; 1988; 24(3):453-9. PubMed ID: 2903710
    [No Abstract]   [Full Text] [Related]  

  • 9. Neural and molecular mechanisms in anxiety.
    Wolkowitz OM; Paul SM
    Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.
    Stephens DN; Kehr W; Duka T
    Adv Biochem Psychopharmacol; 1986; 41():91-106. PubMed ID: 2874697
    [No Abstract]   [Full Text] [Related]  

  • 11. Can social and agonistic interactions be used to detect anxiolytic activity of drugs?
    Krsiak M; Sulcova A; Donat P; Tomasikova Z; Dlohozkova N; Kosar E; Masek K
    Prog Clin Biol Res; 1984; 167():93-114. PubMed ID: 6150490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
    López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
    Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses.
    Macdonald RL; Weddle MG; Gross RA
    Adv Biochem Psychopharmacol; 1986; 41():67-78. PubMed ID: 2874695
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional modulation of GABA function by beta-carbolines.
    Jensen LH; Petersen EN; Honoré T; Drejer J
    Adv Biochem Psychopharmacol; 1986; 41():79-89. PubMed ID: 2874696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can be learned from the effects of benzodiazepines on exploratory behavior?
    File SE
    Neurosci Biobehav Rev; 1985; 9(1):45-54. PubMed ID: 2858081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of benzodiazepine receptors in realizing the anxiolytic effect of compounds on intact rats and on animals with a physical dependence ethanol].
    Burov IuV; Orekhov SN; Iukhananov RIu; Vedernikova NN
    Biull Eksp Biol Med; 1986 Feb; 101(2):170-2. PubMed ID: 2868765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.